Norimichi Koitabashi

6PUBLICATIONS
33CO-AUTHORS
Respiratory diseasesPredictive and prognostic markersFood properties (incl. characteristics and health benefits)Plant physiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 12, 2026
GLP-1 Receptor Agonists in the Rehabilitation of Patients with Heart Failure: Mechanisms, Clinical Evidence, and Future Perspectives.

|Nov 18, 2024
Rivaroxaban for 18 Months Versus 6 Months in Patients With Cancer and Acute Low-Risk Pulmonary Embolism: An Open-Label, Multicenter, Randomized Clinical Trial (ONCO PE Trial).

Yugo Yamashita, Takeshi Morimoto, Nao Muraoka

|Oct 22, 2024
Incidence of Chronic Thromboembolic Pulmonary Hypertension After Pulmonary Embolism in the Era of Direct Oral Anticoagulants: From the COMMAND VTE Registry-2.

Nobutaka Ikeda, Yugo Yamashita, Takeshi Morimoto

|Sep 30, 2024
Selection of Home Treatment and Identification of Low-Risk Patients With Pulmonary Embolism Based on Simplified Pulmonary Embolism Severity Index Score in the Era of Direct Oral Anticoagulants.

Ryusuke Nishikawa, Yugo Yamashita, Takeshi Morimoto

|Oct 19, 2020
DPP-4 inhibitor induces FGF21 expression via sirtuin 1 signaling and improves myocardial energy metabolism.

Nozomi Furukawa, Norimichi Koitabashi, Hiroki Matsui

|Aug 23, 2019
Periostin-expressing cell-specific transforming growth factor-β inhibition in pulmonary artery prevents pulmonary arterial hypertension.

Mitsuru Seki, Nozomi Furukawa, Norimichi Koitabashi

Pageof 1

Frequent Collaborators

3 joint publications

Yoshito Ogihara

3 joint publications

Yugo Yamashita

3 joint publications

Takeshi Morimoto

3 joint publications

Kazuhisa Kaneda